ストックスクリーナーアプリを入手
33.22
0.62%
0.2259
前日終値:
$32.99
開ける：
$33.12
24時間の取引高:
71,656
Relative Volume:
0.12
時価総額：
$1.96B
収益：
$681.88M
当期純損益:
$122.63M
株価収益率:
15.74
EPS:
2.11
ネットキャッシュフロー:
$220.18M
1週間 パフォーマンス:
-3.50%
1か月 パフォーマンス:
-0.82%
6か月 パフォーマンス:
-16.57%
1年 パフォーマンス:
+3.67%
1日の値動き範囲:
$32.92
$33.59
1週間の範囲:
$32.92
$35.99
52週間の値動き範囲:
$28.14
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
33.15 | 1.96B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.04 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.35 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
585.79 | 35.74B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.46 | 35.58B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
251.33 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Exclusive: Harmony Biosciences Leaders Share Strategic Insights at Major Healthcare Conference - StockTitan
Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Investors to Inquire about Securities Investigation - Markets Insider
Harmony Biosciences names new chief commercial officer By Investing.com - Investing.com Australia
Harmony Biosciences appoints Adam Zaeske as Chief Commercial Officer - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Reach Out - Markets Insider
Harmony Biosciences: A Compelling Risk-Reward Opportunity (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences names new chief commercial officer - Investing.com India
Harmony Biosciences Names Adam Zaeske As Chief Commercial Officer -March 24, 2025 at 08:25 am EDT - Marketscreener.com
Harmony Biosciences price target raised to $44 from $42 at Mizuho - MSN
Pharma Leader Who Managed $2B Portfolio Joins Harmony Biosciences as Growth Accelerates - StockTitan
HRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
(HRMY) On The My Stocks Page - Stock Traders Daily
HRMY Down 10.8% In Six Months: How Should You Play The Stock? - Barchart
HRMY Down 10.8% in Six Months: How Should You Play the Stock? - Nasdaq
HRMY Crosses Above Key Moving Average Level - Nasdaq
Expert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 Analysts - Benzinga
Mizuho lifts Harmony Biosciences stock target to $44 - Investing.com India
Mizuho lifts Harmony Biosciences stock target to $44 By Investing.com - Investing.com South Africa
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc.HRMY - PR Newswire
Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating - Marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $44 at Mizuho - StreetInsider.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Harmony Biosciences at Leerink Conference: Expanding Horizons in Rare Disorders - Investing.com UK
Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Repor - GuruFocus.com
Proficio Capital Partners LLC Buys New Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Present at Upcoming Global Healthcare Conferences - MSN
Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - MSN
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire
Amalgamated Bank Buys 2,074 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Principal Financial Group Inc. - Defense World
Equities Analysts Set Expectations for HRMY FY2025 Earnings - Defense World
Harmony Biosciences Reports Record 2024 Revenue, Targets Billion-Dollar Milestone in 2025 - MyChesCo
HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money - ACCESS Newswire
Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Rhumbline Advisers Buys 16,537 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Denali Advisors LLC - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
HC Wainwright Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $70.00 - MarketBeat
Harmony Biosciences Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St
Y Intercept Hong Kong Ltd Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
(HRMY) Trading Report - Stock Traders Daily
Harmony Biosciences Holdings Inc to Host Earnings Call - ACCESS Newswire
Harmony Biosciences Earnings Call Highlights Growth and Challenges - TipRanks
Harmony Biosciences (NASDAQ:HRMY) Shares Down 8.2%Here's Why - MarketBeat
Harmony Biosciences Highlights 2025 Catalysts in Sleep/Wake Franchise - Sleep Review
Demystifying Harmony Biosciences Hldgs: Insights From 11 Analyst Reviews - Benzinga
UBS Adjusts Price Target on Harmony Biosciences to $55 From $56, Keeps Buy Rating - Marketscreener.com
Harmony Biosciences stock target cut to $70 at H.C. Wainwright - Investing.com India
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
1.66%
4.32%
大文字化:
|
ボリューム (24 時間):